3B Blackbio Dx Limited (NSE:3BBLACKBIO)
India · Delayed Price · Currency is INR 1,419.90
-23.40 (-1.62%)
At close: Sep 11, 2026
3B Blackbio Dx Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 12,221 | 9,648 | 13,853 | 6,605 | 3,121 | 2,562 | |
Market Cap Growth | 0.51% | -30.35% | 109.73% | 111.63% | 21.82% | 19.86% |
Enterprise Value | 11,319 | 8,987 | 13,224 | 6,048 | 2,994 | 2,434 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 22.01 | 16.10 | 29.05 | 20.58 | 12.03 | 7.96 |
PS Ratio | 7.98 | 6.80 | 14.36 | 8.88 | 5.03 | 2.93 |
PB Ratio | 3.69 | 2.91 | 5.11 | 2.93 | 1.59 | 1.49 |
P/TBV Ratio | 3.77 | 2.97 | 5.16 | 2.96 | 1.62 | 1.67 |
P/FCF Ratio | 45.32 | 35.78 | 32.63 | 24.98 | 17.09 | 7.31 |
P/OCF Ratio | 23.29 | 18.39 | 31.95 | 24.51 | 15.39 | 6.86 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.39 | 6.33 | 13.71 | 8.13 | 4.82 | 2.78 |
EV/EBITDA Ratio | 20.52 | 13.18 | 26.21 | 18.07 | 10.04 | 5.53 |
EV/EBIT Ratio | 23.09 | 14.25 | 26.79 | 18.66 | 10.34 | 5.62 |
EV/FCF Ratio | 41.97 | 33.33 | 31.15 | 22.87 | 16.40 | 6.94 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.06 | 0.07 | 0.01 | 0.02 | 0.07 | 0.06 |
Debt / FCF Ratio | - | 0.18 | 0.01 | 0.03 | 0.11 | 0.07 |
Net Debt / Equity Ratio | -0.29 | -0.29 | -0.25 | -0.06 | -0.02 | -0.15 |
Net Debt / EBITDA Ratio | -1.77 | -1.41 | -1.36 | -0.38 | -0.13 | -0.60 |
Net Debt / FCF Ratio | - | -3.55 | -1.61 | -0.48 | -0.22 | -0.75 |
Asset Turnover | - | 0.42 | 0.36 | 0.32 | 0.31 | 0.45 |
Inventory Turnover | - | 2.72 | 3.04 | 2.69 | 2.32 | 5.17 |
Quick Ratio | - | 4.12 | 5.67 | 2.84 | 2.82 | 3.48 |
Current Ratio | - | 5.27 | 7.11 | 7.04 | 8.05 | 4.83 |
Return on Equity (ROE) | - | 19.89% | 19.21% | 15.24% | 14.10% | 20.10% |
Return on Assets (ROA) | - | 11.70% | 11.35% | 8.76% | 8.91% | 14.05% |
Return on Invested Capital (ROIC) | 15.79% | 22.41% | 17.72% | 11.60% | 12.60% | 24.74% |
Return on Capital Employed (ROCE) | - | 18.50% | 17.80% | 14.10% | 14.50% | 24.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.54% | 6.21% | 3.44% | 4.86% | 8.31% | 12.57% |
FCF Yield | 2.21% | 2.79% | 3.06% | 4.00% | 5.85% | 13.69% |
Payout Ratio | - | 5.71% | 5.38% | 6.83% | 17.11% | 48.02% |
Buyback Yield / Dilution | 0.85% | - | - | -0.02% | -14.34% | -0.00% |